Weekly News Amount
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
NuProbe's TOE HOLD PROBE - based technology is the initial research and development at Harvard University's Vis Institute of Bioengineering and Rice University, and is authorized by its patent. This is a breakthrough molecular technology that can be used to detect various diseases including cancer. NuProbe's technology can very sensitively identify mutants in the early stage, improve the detection rate of diseases and help guide treatment decisions that can increase patients' chances of survival


Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${e.date}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info


Intelligence 0 Research Briefs


Competitors 4 Competitors
Company Industry Series Amount Announced Date


anobiomed is a cancer immunotherapy research and development company, focusing on technology research and development in tumor cell biology and immunology and other related fields. It has an antibody screening platform, a clinical lentivirus production platform and a cell gene editing platform, and research and development involves CART technology, which is applied to blood tumor patients to extend the remission period


series A

Tens of millions CNY



POLARIS BIOLOGY is a company founded by teams from Cambridge University and Zhejiang University. It is committed to providing effective drug treatment programs for common malignant tumor patients and doctors, significantly improving the survival rate and quality of life of patients, transforming the latest research results of robot scientists into applied technologies for tumor treatment, and creating an internationally leading individualized guiding drug use method at cell level


series B

70 million CNY



RuiDiShengWu is a research and development company of electromagnetic tumor treatment methods. It has developed nanosecond electric pulse ablation tumor products with higher voltage and higher frequency. It is an upgraded product of microsecond electric pulse irreversible electroporation technology. Ultra - short nanosecond pulse can form high-density nanopores on cell membrane and internal organelle membrane. In addition to destroying tumor cells, it may also trigger host immune response to remove tumor cells and inhibit tumor neovascularization, which may reduce tumor invasion, metastasis and recurrence


series A

Tens of millions CNY



Huichuanyi is a medical and health service company, focusing on building a POCT platform. Its main product is colloidal gold immunoassay analyzer, which is used for rapid diagnosis of tumor markers such as hepatitis A, hepatitis B, hepatitis C and AIDS, and heart diseases


series Unknow

25 million CNY